A patient was prescribed Diazepam (Valium) 5 mg TID 6 months ago and now must take 10 mg TID to achieve the same effects. The nurse recognized which as the rationale for change?
Explanation & Rationale
Choice A rationale Dependence refers to a physiological state where the body has adapted to the presence of a drug, leading to withdrawal symptoms if the substance is abruptly discontinued. While a patient taking Diazepam for six months likely has some level of physiological dependence, the specific need for a higher dose to achieve the same therapeutic effect is a separate pharmacological phenomenon. Dependence is more about the physical requirement for the drug rather than the shifting efficacy of the dosage. Choice B rationale Tolerance occurs when the body's response to a drug decreases over time with repeated exposure, requiring an increased dosage to produce the same effect. In the case of benzodiazepines like Diazepam, the central nervous system receptors become less sensitive to the medication. This necessitates a shift from 5 mg to 10 mg to maintain the initial level of anxiety relief or sedation. The normal therapeutic range for Diazepam varies widely, but escalating doses are classic clinical indicators of tolerance. Choice C rationale Addiction is a complex primary, chronic disease of brain reward, motivation, and memory. It is characterized by compulsive drug seeking and use despite harmful consequences. While tolerance can be a component of addiction, the two are not synonymous. A patient may develop tolerance to a prescribed medication under medical supervision without exhibiting the cravings, loss of control, and social impairment that define clinical addiction. The prompt describes a pharmacological adjustment rather than a behavioral or psychological syndrome. Choice D rationale Disinhibition is a side effect sometimes seen with benzodiazepines where the drug reduces the social or emotional "brakes" on a patient's behavior. This can lead to unexpected aggression, impulsivity, or euphoria. Disinhibition does not explain why a patient would need a larger dose to achieve the same therapeutic effect. It is a qualitative change in behavior resulting from the drug's impact on the frontal lobe, rather than a quantitative change in the drug's potency or efficacy.